SCHEMBL22985000

SCHEMBL22985000

N#Cc1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3C#N)ccc2-n2c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c(-n2c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.40
FEN1 P39748 2/20 0.40
KIF11 P52732 2/20 0.35
AR P10275 6/20 0.35
STS P08842 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.31
PGR P06401 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
DGAT1 O75907 1/20 0.31
SOAT1 P35610 1/20 0.31
KCNH2 Q12809 1/20 0.31
XDH P47989 2/20 0.31
KDM1A O60341 1/20 0.31
NSD2 O96028 1/20 0.30
CYP2C9 P11712 1/20 0.30
SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20849551 0.98 ALOX5AP (0.38) ALOX5APFEN1KIF11ARSTS
SCHEMBL22985133 0.96 ALOX5AP (0.40) ALOX5APFEN1KIF11ARSTS
SCHEMBL22985502 0.96 ALOX5AP (0.41) ALOX5APFEN1KIF11ARSTS
SCHEMBL22985077 0.96 ALOX5AP (0.41) ALOX5APFEN1KIF11ARSTS
SCHEMBL20848760 0.95 KIF11 (0.39) ALOX5APFEN1KIF11ARPTGDR2
SCHEMBL20848449 0.94 ALOX5AP (0.38) ALOX5APFEN1KIF11ARSTS
SCHEMBL20848697 0.94 ALOX5AP (0.39) ALOX5APFEN1KIF11ARSTS
SCHEMBL22985366 0.94 ALOX5AP (0.42) ALOX5APFEN1KIF11ARSTS
SCHEMBL22985309 0.94 KIF11 (0.38) ALOX5APFEN1KIF11ARPTGDR2
SCHEMBL20848443 0.94 AR (0.36) ALOX5APFEN1KIF11ARSTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885KIF11 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.